The Center for Intelligent Imaging, also called ci2, will apply AI to create new ways to examine the inside of the human body and to evaluate health and diseases. UCSF researchers will collaborate with engineers from Nvidia, a technology company that specializes in AI computing, to develop tools and infrastructure to incorporate AI into clinical practice.
Researchers in the center will use patient images and clinical data from UCSF Health to develop, test and validate deep learning algorithms.
“The volume of medical imaging has been rapidly increasing and radiologists are struggling to keep up with the sheer number of images,” said Sharmila Majumdar, PhD, a professor and vice chair in the UCSF radiology and biomedical imaging department, according to a news release. “Ci2 aims to impact the entire value chain of imaging, from the time the patient comes for a scan to the final delivery of individualized, quantitative, prognostic and care-defining information.”
More articles on artificial intelligence:
VUMC researchers use AI to detect heart disease phenotypes
Healthcare execs are investing in, optimistic about future of AI: Optum report
Viewpoint: AI is still years away from transforming oncology
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
